UK-based patient-recruitment and trial-management business Synexus has opened a regional office for Eastern Europe in Wroclaw, Poland.
The new 3,000 sq ft office in Wroclaw’s Sky Tower will enable Synexus further to strengthen a regional team with more than a decade’s experience in Eastern Europe, the company noted.
The team will be responsible for Synexus’ patient-engagement programmes and for managing the company’s nine dedicated research centres across Poland, Hungary, Romania, Ukraine and Bulgaria.
Wroclaw was the first of four Synexus sites in Poland, where last year the company acquired Warsaw-based clinical research organisation Medical Centre Osteomed. The other two sites are in Gdynia and Katowice.
In August 2009, Synexus completed the acquisition of CLCC, which operated three clinical trial centres in the major Polish conurbations of Warsaw, Gdynia and Katowice. Synexus, which has been active in Poland since 2006, expanded its operations in Gydnia the following July.
Wroclaw was also the first Synexus site to be selected for Pfizer’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) network.
These sites have early access to data from the Pfizer portfolio and advanced information on clinical trials to be sponsored by the US-based multinational.
They are also involved in journal publications, protocol design, advisory boards and best-practice sharing across the INSPIRE network.
Commenting on the latest investment, Synexus regional managing director Dr Radoslaw Janiak said the company’s success in Eastern Europe was “based on our ability to deliver patients and quality data to our clients in pharma”.